{"id":542105,"date":"2021-05-06T22:48:02","date_gmt":"2021-05-06T22:48:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=542105"},"modified":"2021-05-06T22:48:02","modified_gmt":"2021-05-06T22:48:02","slug":"knee-osteoarthritis-market-insight-epidemiology-and-market-forecast-analysis-report","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/knee-osteoarthritis-market-insight-epidemiology-and-market-forecast-analysis-report_542105.html","title":{"rendered":"Knee Osteoarthritis Market Insight, Epidemiology, and Market Forecast Analysis Report"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1620296729.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Knee Osteoarthritis Market Insight, Epidemiology, and Market Forecast Analysis Report\" src=\"https:\/\/www.abnewswire.com\/uploads\/1620296729.jpeg\" alt=\"Knee Osteoarthritis Market Insight, Epidemiology, and Market Forecast Analysis Report\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>What is <\/strong><strong>Knee Osteoarthritis?<\/strong><\/p>\n<p style=\"text-align: justify;\">Knee Osteoarthritis is defined by degeneration of the knee&rsquo;s articular cartilage&mdash;the flexible, slippery material that normally protects bones from joint friction and impact.<\/p>\n<p style=\"text-align: justify;\"><strong>How Knee Osteoarthritis affected population? <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Knee Osteoarthritis Epidemiology &ndash; <\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per the Arthritis Foundation, one in two adults will develop symptoms of knee Osteoarthritis during their lives, one in four develops hip Osteoarthritis by age 85 and one in 12 people of 60 years or older have hand Osteoarthritis.<\/li>\n<li>The number of people affected with symptomatic Osteoarthritis is likely to increase due to the aging of the population and the obesity epidemic.<\/li>\n<li>Among 60 years of age or older, the prevalence of symptomatic knee Osteoarthritis is approximately 10% in men and 13% in women.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">To know more, request sample pages @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/knee-osteoarthritis-market\"><strong>Knee Osteoarthritis Market Landscape<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Knee Osteoarthritis Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">According to DelveInsight, <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/knee-osteoarthritis-market\"><strong>Knee Osteoarthritis market<\/strong><\/a> in 7MM is expected to change in the study period 2017-2030.<\/p>\n<p style=\"text-align: justify;\">The increasing prevalence, longevity of the life, and advanced lifestyles are key drivers for global Osteoarthritismarket. Medications available in Osteoarthritismarket are encouraged to focus on the development of biomarkers along with focus on regenerative medicine.<\/p>\n<p style=\"text-align: justify;\">The therapies under development are focused on novel approaches to treat\/improve the disease condition. The novel targets and cell therapies changed the market size with huge impetus to research.&nbsp;<\/p>\n<p style=\"text-align: justify;\">Nevertheless, the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/knee-osteoarthritis-market\"><strong>Knee Osteoarthritis market size<\/strong><\/a> is expected to grow remarkably during the period of forecast due to a slew of growth drivers in place. The world&rsquo;s population continues to age with increased life expectancy; if Knee Osteoarthritis is treatable, it may result in an increased diagnosed rate and rising healthcare expenditure, which are the prime drivers of growth for the Knee Osteoarthritis market. Additionally, the launches of upcoming therapies will also contribute to the overall growth of the Knee Osteoarthritis market during the forecast period of 2020&ndash;2030.&nbsp;&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Which are the leading companies in Knee Osteoarthritis market? &nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Companies across the globe are diligently working toward the development of new therapies for Knee Osteoarthritis treatment. Major players, such as <strong>Centrexion Therapeutics, Pfizer, Eli Lilly, Ampio Pharmaceuticals, Galapagos NV, Cytonics, Flexion Therapeutics, and others are involved in developing therapies for the disease. Therefore, the entry of new therapies by these companies is expected to fuel market growth. Ampion (Ampio Pharmaceuticals), Invossa (TG-C) (Kolon TissueGene), CNTX-4975 (Centrexion Therapeutics), Tanezumab (Pfizer\/Eli Lilly), JTA-004 (Bone Therapeutics), FX201 (Flexion Therapeutics), GLPG1972 (Galapagos NV), <\/strong>etc. along with others are in the various stages of development for the treatment of Osteoarthritis.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Knee Osteoarthritis<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Knee Osteoarthritis<\/p>\n<p style=\"text-align: justify;\">4. Knee Osteoarthritis : Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Knee Osteoarthritis : Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Knee Osteoarthritis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Knee Osteoarthritis Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">13. Knee Osteoarthritis : Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\"><span>16. Access and Reimbursement Overview of Knee Osteoarthritis<\/span><\/p>\n<p style=\"text-align: justify;\"><span>17. KOL Views<\/span><\/p>\n<p style=\"text-align: justify;\"><span>18. Market Drivers<\/span><\/p>\n<p style=\"text-align: justify;\"><span>19. Market Barriers<\/span><\/p>\n<p style=\"text-align: justify;\"><span>20. Appendix<\/span><\/p>\n<p style=\"text-align: justify;\"><span>21. DelveInsight Capabilities<\/span><\/p>\n<p style=\"text-align: justify;\"><span>22. Disclaimer<\/span><\/p>\n<p style=\"text-align: justify;\"><span>23. About DelveInsight<\/span><\/p>\n<p style=\"text-align: justify;\"><span><em>*The table of contents is not exhaustive; the final content may vary.&nbsp;<\/em><\/span><\/p>\n<p style=\"text-align: justify;\">Request sample pages for more information on&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/knee-osteoarthritis-market\"><strong>Knee Osteoarthritis Market Report<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=knee-osteoarthritis-market-insight-epidemiology-and-market-forecast-analysis-report\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=knee-osteoarthritis-market-insight-epidemiology-and-market-forecast-analysis-report\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU5 (Germany, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/knee-osteoarthritis-market-insight-epidemiology-and-market-forecast-analysis-report_542105.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-542105","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/542105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=542105"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/542105\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=542105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=542105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=542105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}